|
1
|
Cecconi M, Evans L, Levy M and Rhodes A:
Sepsis and septic shock. Lancet. 392:75–87. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vincent JL, Marshall JC, Namendys-Silva
SA, François B, Martin-Loeches I, Lipman J, Reinhart K, Antonelli
M, Pickkers P, Njimi H, et al: Assessment of the worldwide burden
of critical illness: The intensive care over nations (ICON) audit.
Lancet Respir Med. 2:380–386. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Singer BH, Dickson RP, Denstaedt SJ,
Newstead MW, Kim K, Falkowski NR, Erb-Downward JR, Schmidt TM,
Huffnagle GB and Standiford TJ: Bacterial dissemination to the
brain in Sepsis. Am J Respir Crit Care Med. 197:747–756.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Merx MW and Weber C: Sepsis and the heart.
Circulation. 116:793–802. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Meneses G, Cardenas G, Espinosa A, Rassy
D, Pérez-Osorio IN, Bárcena B, Fleury A, Besedovsky H, Fragoso G
and Sciutto E: Sepsis: Developing new alternatives to reduce
neuroinflammation and attenuate brain injury. Ann N Y Acad Sci.
1437:43–56. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hato T, Maier B, Syed F, Myslinski J,
Zollman A, Plotkin Z, Eadon MT and Dagher PC: Bacterial sepsis
triggers an antiviral response that causes translation shutdown. J
Clin Invest. 129:296–309. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fowler AA III, Truwit JD, Hite RD, Morris
PE, DeWilde C, Priday A, Fisher B, Thacker LR II, Natarajan R,
Brophy DF, et al: Effect of vitamin C infusion on organ failure and
biomarkers of inflammation and vascular injury in patients with
sepsis and severe acute respiratory failure: The CITRIS-ALI
randomized clinical trial. JAMA. 322:1261–1270. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fernandez FG, Kosinski AS, Furnary AP,
Onaitis M, Kim S, Habib RH, Tong BC, Cowper P, Boffa D, Jacobs JP,
et al: Differential effects of operative complications on survival
after surgery for primary lung cancer. J Thorac Cardiovasc Surg.
155:1254–1264.e1. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vazquez-Medina JP, Tao JQ, Patel P,
Bannitz-Fernandes R, Dodia C, Sorokina EM, Feinstein SI, Chatterjee
S and Fisher AB: Genetic inactivation of the phospholipase A2
activity of peroxiredoxin 6 in mice protects against LPS-induced
acute lung injury. Am J Physiol Lung Cell Mol Physiol.
316:L656–L668. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Guo RF and Ward PA: Role of oxidants in
lung injury during sepsis. Antioxid Redox Signal. 9:1991–2002.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yi L, Chang M, Zhao Q, Zhou Z, Huang X,
Guo F and Huan J: Genistein-3'-sodium sulphonate protects against
lipopolysaccharide-induced lung vascular endothelial cell apoptosis
and acute lung injury via BCL-2 signalling. J Cell Mol Med.
24:1022–1035. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Swisher EM, Lin KK, Oza AM, Scott CL,
Giordano H, Sun J, Konecny GE, Coleman RL, Tinker AV, O'Malley DM,
et al: Rucaparib in relapsed, platinum-sensitive high-grade ovarian
carcinoma (ARIEL2 Part 1): An international, multicentre,
open-label, phase 2 trial. Lancet Oncol. 18:75–87. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hennessy EJ, Parker AE and O'Neill LA:
Targeting Toll-like receptors: Emerging therapeutics? Nat Rev Drug
Discov. 9:293–307. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
14
|
Seeley JJ, Baker RG, Mohamed G, Bruns T,
Hayden MS, Deshmukh SD, Freedberg DE and Ghosh S: Induction of
innate immune memory via microRNA targeting of chromatin
remodelling factors. Nature. 559:114–119. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gotts JE and Matthay MA: Sepsis:
Pathophysiology and clinical management. BMJ.
353(i1585)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhu M, Zhang W, Ma J, Dai Y, Zhang Q, Liu
Q, Yang B and Li G: MicroRNA-139-5p regulates chronic inflammation
by suppressing nuclear factor-κB activity to inhibit cell
proliferation and invasion in colorectal cancer. Exp Ther Med.
18:4049–4057. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Qu Y, Wu J, Chen D, Zhao F, Liu J, Yang C,
Wei D, Ferriero DM and Mu D: MiR-139-5p inhibits HGTD-P and
regulates neuronal apoptosis induced by hypoxia-ischemia in
neonatal rats. Neurobiol Dis. 63:184–193. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Huang N, Guo W, Ren K, Li W, Jiang Y, Sun
J, Dai W and Zhao W: LncRNA AFAP1-AS1 Supresses miR-139-5p and
promotes cell proliferation and chemotherapy resistance of
non-small cell lung cancer by competitively upregulating RRM2.
Front Oncol. 9(1103)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang Y, Wang X, Liu W and Zhang L: Role of
the Rho/ROCK signaling pathway in the protective effects of fasudil
against acute lung injury in septic rats. Mol Med Rep.
18:4486–4498. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ruiz S, Vardon-Bounes F, Merlet-Dupuy V,
Conil JM, Buléon M, Fourcade O, Tack I and Minville V: Sepsis
modeling in mice: Ligation length is a major severity factor in
cecal ligation and puncture. Intensive Care Med Exp.
4(22)2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhuo Y, Li D, Cui L, Li C, Zhang S, Zhang
Q, Zhang L, Wang X and Yang L: Treatment with
3,4-dihydroxyphenylethyl alcohol glycoside ameliorates
sepsis-induced ALI in mice by reducing inflammation and regulating
M1 polarization. Biomed Pharmacother. 116(109012)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Matute-Bello G, Downey G, Moore BB,
Groshong SD, Matthay MA, Slutsky AS and Kuebler WM: An official
American Thoracic Society workshop report: Features and
measurements of experimental acute lung injury in animals. Am J
Respir Cell Mol Biol. 44:725–738. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Shang G, Jin Y, Zheng Q, Shen X, Yang M,
Li Y and Zhang L: Histology and oncogenic driver alterations of
lung adenocarcinoma in Chinese. Am J Cancer Res. 9:1212–1223.
2019.PubMed/NCBI
|
|
25
|
Englert JA, Bobba C and Baron RM:
Integrating molecular pathogenesis and clinical translation in
sepsis-induced acute respiratory distress syndrome. JCI Insight.
4(e124061)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Konduri K, Gallant JN, Chae YK, Giles FJ,
Gitlitz BJ, Gowen K, Ichihara E, Owonikoko TK, Peddareddigari V,
Ramalingam SS, et al: EGFR fusions as novel therapeutic targets in
lung cancer. Cancer Discov. 6:601–611. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Dejager L, Pinheiro I, Dejonckheere E and
Libert C: Cecal ligation and puncture: The gold standard model for
polymicrobial sepsis? Trends Microbiol. 19:198–208. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hong HC, Chuang CH, Huang WC, Weng SL,
Chen CH, Chang KH, Liao KW and Huang HD: A panel of eight microRNAs
is a good predictive parameter for triple-negative breast cancer
relapse. Theranostics. 10:8771–8789. 2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Du F, Cao T, Xie H, Li T, Sun L, Liu H,
Guo H, Wang X, Liu Q, Kim T, et al: KRAS Mutation-Responsive
miR-139-5p inhibits colorectal cancer progression and is repressed
by Wnt Signaling. Theranostics. 10:7335–7350. 2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xiu D, Liu L, Cheng M, Sun X and Ma X:
Knockdown of lncRNA TUG1 enhances radiosensitivity of prostate
cancer via the TUG1/miR-139-5p/SMC1A Axis. Onco Targets Ther.
13:2319–2331. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wen J, Wang G, Xie X, Lin G, Yang H, Luo
K, Liu Q, Ling Y, Xie X, Lin P, et al: Prognostic value of a
Four-miRNA signature in patients with lymph node positive
locoregional esophageal squamous cell carcinoma undergoing complete
surgical resection. Ann Surg. 273:523–531. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pajic M, Froio D, Daly S, Doculara L,
Millar E, Graham PH, Drury A, Steinmann A, de Bock CE,
Boulghourjian A, et al: MiR-139-5p modulates radiotherapy
resistance in breast cancer by repressing multiple gene networks of
DNA repair and ROS defense. Cancer Res. 78:501–515. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zou F, Mao R, Yang L, Lin S, Lei K, Zheng
Y, Ding Y, Zhang P, Cai G, Liang X and Liu J: Targeted deletion of
miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes
intestinal inflammation and colorectal cancer. FEBS J.
283:1438–1452. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Li C, Ma D, Yang J, Lin X and Chen B:
MiR-202-5p inhibits the migration and invasion of osteosarcoma
cells by targeting ROCK1. Oncol Lett. 16:829–834. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Roberto GM, Delsin LEA, Vieira GM, Silva
MO, Hakime RG, Gava NF, Engel EE, Scrideli CA, Tone LG and
Brassesco MS: ROCK1-PredictedmicroRNAs dysregulation contributes to
tumor progression in ewing sarcoma. Pathol Oncol Res. 26:133–139.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tian K, Sun D, Chen M, Yang Y, Wang F, Guo
T and Shi Z: Long Noncoding RNA X-Inactive specific transcript
facilitates cellular functions in melanoma via miR-139-5p/ROCK1
Pathway. Onco Targets Ther. 13:1277–1287. 2020.PubMed/NCBI View Article : Google Scholar
|
